Thermo Fisher Scientific Inc.
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3025% above fair value
$682.65−14.35 (-2.06%)
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Europe Revenue: $3,311M in Q2 2026, up 17.0% from a year earlier.
Latest, Q2 2026
3,311
Period ended Jun 30, 2026
Change on a year earlier
+17.0%
2,830 in Q2 2025
History
28 quarters
Since Q3 2019
Sources
23
Documents cited below
Where the Q2 2026 figure comes from
“|| Europe | 3,311 | 2,830 | 6,268 | 5,454”
Source: SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗
Reported in SEC 10-K / 10-Q Note 6 (Disaggregation of Revenues by Geography).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Thermo Fisher Scientific Europe Revenue ($M), quarterly Q3 2019–Q2 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/rev-geo-europe
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.